Roberta Benedetto, Scientist; Assay.Works
Title: SSURFE2R-Based Assays for Mitochondrial Toxicity Screening and Intestinal Transporter-Mediated Drug Delivery
Thomas Licher, Head of Integrated Drug Discovery; Sanofi
Title: SSM-Based Technology for Screening of Transporter Modulating Compounds – a Case Study
Transport proteins and pumps are getting more established as drug targets. However, the set of available technologies for screening and hit validation is lean. In session four of the Transporter Webinar Series we hear from experts in the pharma field how SSM-based electrophysiology can support transporter drug screening as a potent tool.
Date: 21. October 2021
Time: 4PM CEST, 10AM EDT
back to transporter series overview
Register for our monthly Newsletter and we will keep you informed.